How not to publicize medical research in the age of overhype

In a publishing climate polluted with nonstop noise, irresistible clickbait and non-newsworthy nonsense, it can be tempting for researchers as well as reporters to subtly sensationalize findings and conclusions from clinical studies.

Or, as put by researcher Steven Salzberg, PhD, of Johns Hopkins:

“Journalists and scientists need to work harder to come up with headlines that excite people about the potential of science without making it seem that we’ve already cured humankind’s most devastating diseases.”

Salzberg says more and gives some recent examples in a March 7 Forbes post: 

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.